Venez partager avec nous la science et l’historique de la découverte du traitement contre le VIH. Trois conférenciers décriront différents aspects de la mise au point de médicaments antiviraux.

14h30 : Erik De Clercq

Pioneer in antiviral therapies who co-invented with Antonín Holý (Prague, Czech Republic), a key class of drugs to combat HIV, and discovered a.o. a stem cell mobilizer and drugs against herpes zoster. https://www.erikdeclercq.org/

“Fifty Years in Search of Selective Antiviral Drugs“

15h30 : John C. Martin

Former CEO and chairman of Gilead Sciences who has made vital contributions to the development of antiviral medications used to treat HIV/AIDS, hepatitis C, hepatitis B, cytomegalovirus, and influenza. http://www.nasonline.org/programs/awards/2019-nas-awards/Martin.html

“Perspectives on Nucleotide Research for Antiviral Drugs“

16h30 : pause-café

17h00 : Renilde Loeckx-Drozdiak

Former Ambassador of Belgium in the Czech Republic. She has been familiarized with the discovery and development of the first anti-HIV drugs by Antonín Holý in Prague and Erik de Clerq in Leuven as well as by John C. Martin in the USA. She wrote a book telling this story: “Cold War Triangle – How Scientists in East and West Tamed HIV”

“International Politics and Science in the Fight against AIDS”

18h00 : moment convivial